Search Results - "Holdford, Diane"

A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma by Krauze, Andra V., MD, Myrehaug, Sten D., MD, Chang, Michael G., MD, Holdford, Diane J, Smith, Sharon, Shih, Joanna, MD, Tofilon, Philip J., PhD, Fine, Howard A., MD, Camphausen, Kevin, MD

“…Purpose Valproic acid (VPA) is an antiepileptic agent with histone deacetylase inhibitor (HDACi) activity shown to sensitize glioblastoma (GBM) cells to…”
Get full text

Moderately Hypofractionated Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Prostate Cancer: Five-Year Toxicity Results From a Prospective Phase I/II Trial by Ricco, Anthony, Mukhopadhyay, Nitai, Deng, Xiaoyan, Holdford, Diane, Skinner, Vicki, Saraiya, Siddharth, Moghanaki, Drew, Anscher, Mitchell S, Chang, Michael G

“…In this phase I/II trial, 5-year physician-assessed toxicity and patient reported quality of life data is reported for patients undergoing moderately…”
Get full text

Late toxicity in long-term survivors from a phase 2 study of concurrent radiation therapy, temozolomide and valproic acid for newly diagnosed glioblastoma by Krauze, Andra V, Mackey, Megan, Rowe, Lindsay, Chang, Michal G, Holdford, Diane J, Cooley, Theresa, Shih, Joanna, Tofilon, Philip J, Camphausen, Kevin

“…Valproic acid (VPA) is an antiepileptic agent with histone deacetylase inhibitor activity shown to enhance overall survival and progression free survival in…”
Get full text

Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results by Lauve, Andrew, Morris, Monica, Schmidt-Ullrich, Rupert, Wu, Qiuwen, Mohan, Radhe, Abayomi, Olubumni, Buck, David, Holdford, Diane, Dawson, Kathryn, Dinardo, Laurence, Reiter, Evan

“…To perform a Phase I radiation dose-escalation trial to determine the maximal tolerable dose (MTD) deliverable to the gross tumor volume (GTV) using an…”
Get more information

Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience by Arthur, Douglas W, Koo, Derrick, Zwicker, Robert D, Tong, Shidong, Bear, Harry D, Kaplan, Brian J, Kavanagh, Brian D, Warwicke, Laurel A, Holdford, Diane, Amir, Cyrus, Archer, Kellie J, Schmidt-Ullrich, Rupert K

“…The use of partial breast brachytherapy (PBB) after lumpectomy for selected patients with early-stage breast cancer reduces the adjuvant radiotherapy treatment…”
Get more information

Five-year results from a phase I/II study of moderately hypofractionated intensity-modulated radiation therapy (IMRT) for localized prostate cancer including simultaneously integrated boost and pelvic lymph node (LN) coverage by Ricco, Anthony, Mukhopadhyay, Nitai, Holdford, Diane, Skinner, Vicki, Saraiya, Siddharth, Moghanaki, Drew, Anscher, Mitchell Steven, Chang, Michael G., Deng, Xiaoyan

“…Abstract only 299 Background: This study reports the 5 year toxicity and efficacy data of a phase I/II trial of moderately hypofractionated intensity modulated…”
Get full text

Prostate Cancer Education in African American Churches by Weinrich, Sally, Holdford, Diane, Boyd, Marlyn, Creanga, Dana, Cover, Kay, Johnson, Alonzo, Frank-Stromborg, Marilyn, Weinrich, Martin

“…The use of churches as recruitment sites of African Americans into health promotion activities is a popular theme in the 1990s literature. This research…”
Get full text

ACTR-57. DOES THE ADDITION OF VALPROIC ACID TO CONCURRENT RADIATION THERAPY AND TEMOZOLOMIDE IMPROVE PATIENT OUTCOME? – CORRELATIVE ANALYSIS OF RTOG 0525, SEER AND A PHASE II NCI TRIAL by Krauze, Andra, Myrehaug, Sten, Chang, Michael, Holdford, Diane, Smith, Sharon, Shih, Joanna, Tofilon, Philip, Fine, Howard, Rowe, Lindsay, Gilbert, Mark R, Camphausen, Kevin

Get full text

Phase II study of lovastatin to prevent rectal injury from radiation therapy for prostate cancer by Anscher, Mitchell Steven, Chang, Michael G., Moghanaki, Drew, Rosu, Mihaela, Mikkelsen, Ross, Holdford, Diane, Skinner, Vicki, Grob, B Mayer, Sanyal, Arun J., Mukhopadhyay, Nitai

“…Abstract only 120 Background: Late radiation induced rectal injury remains an issue. Large population based studies indicate an incidence of at least 15%…”
Get full text

A Phase II Study to Prevent Radiation-induced Rectal Injury With Lovastatin by Anscher, Mitchell S, Chang, Michael G, Moghanaki, Drew, Rosu, Mihaela, Mikkelsen, Ross B, Holdford, Diane, Skinner, Vicki, Grob, Baruch M, Sanyal, Arun, Wang, Aiping, Mukhopadhyay, Nitai D

“…Physician reported symptomatic late rectal injury occurs in about 5% to 25% of patients treated with radiation therapy for prostate cancer, depending on the…”
Get full text

Phase 1/2 study of hypofractionated intensity-modulated radiation therapy for prostate cancer including simultaneously integrated boost by Chang, Michael G., Mukhopadhyay, Nitai, Holdford, Diane, Skinner, Vicki, Saraiya, Siddharth, Moghanaki, Drew, Anscher, Mitchell S.

“…This study evaluates the safety and efficacy of moderately hypofractionated radiation therapy (RT) with simultaneous integrated boost (HSIB) intensity…”
Get full text

Lovastatin may reduce the risk of erectile dysfunction following radiation therapy for prostate cancer by Anscher, Mitchell S, Chang, Michael G, Moghanaki, Drew, Rosu, Mihaela, Mikkelsen, Ross B, Holdford, Diane, Skinner, Vicki, Grob, B Mayer, Sanyal, Arun, Wang, Aiping, Mukhopadhyay, Nitai D

Get more information

AT-33A PHASE II STUDY OF CONCURRENT RADIATION THERAPY, TEMOZOLOMIDE AND THE HISTONE DEACETYLASE INHIBITOR VALPROIC ACID FOR PATIENTS WITH GLIOBLASTOMA MULTIFORME by Krauze, Andra V., Myrehaug, Sten D., Chang, Michael G., Holdford, Diane J., Smith, Sharon, Shih, Joanna, Tofilon, Peter, Fine, Howard, Camphausen, Kevin A.

“…BACKGROUND: Glioblastoma (GBM) remains an aggressive brain tumor with poor prognosis. Valproic acid (VPA) is an antiepileptic agent that has been shown to have…”
Get full text

AT-33 A PHASE II STUDY OF CONCURRENT RADIATION THERAPY, TEMOZOLOMIDE AND THE HISTONE DEACETYLASE INHIBITOR VALPROIC ACID FOR PATIENTS WITH GLIOBLASTOMA MULTIFORME by Krauze, Andra V, Myrehaug, Sten D, Chang, Michael G, Holdford, Diane J, Smith, Sharon, Shih, Joanna, Tofilon, Peter, Fine, Howard, Camphausen, Kevin A

“…BACKGROUND: Glioblastoma (GBM) remains an aggressive brain tumor with poor prognosis. Valproic acid (VPA) is an antiepileptic agent that has been shown to have…”
Get full text

95 Breast brachytherapy - a method of catheter placement offering improvements in cost, time, safety and accuracy by Arthur, Douglas W., Warmwicke, Laurel A., Zwicker, Robert D., Holdford, Diane, Manning, Matthew A., Amfield, Mark R.

Get full text